A recent study demonstrated a lack of correlation between in vivo18F-AV1451 retention and tau pathology in cases with non-AD tauopathy (Josephs et al., 2016; Marquie et al., 2017; Smith et al., 2017a). Here, MAPT is linked to Alzheimer disease.